Vendor source
Reviewed 11 May 2026
Completeness Strong (64%)
Myrian XP-Prostate option AI
Intrasense by GuerbetMyrian XP-Prostate option AI includes an AI developed by Guerbet. An AI algorithm to segment the prostate, performs rapid, reliable analysis, identify lesions and ensure patient follow-up. It enables automatic prostate segmentation and volume calculation, automatic calculation of PSA density, automatic detection of suspicious areas of PIRADS > 3 thanks to artificial intelligence.
Currently only available through Myrian platform
No papers to support — we monitor for new evidence.
General Information
Product name
Company
Modality
Main task
Not specified
Subspeciality
Disease targeted
Regulatory Information
Pathway:
MDR
Class:
Class IIa
Verified by Health AI Register
Other certifications
Not specified
Evidence & Research
No research papers or evidence on file yet.
The registry monitors publications for new evidence.
Technical Specifications
Patient population age
Not specified
Input
Input format
Output
Output format
Integration
Deployment
Trigger for analysis
Processing time
Population
Market Presence
On market since
AI Platforms
Resellers
Not specified
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Based on
Source: Vendor | First published: Jun 6, 2024 | Last updated: May 11, 2026